Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine
Kanako Kimura, Hidetsugu Asada, Asuka Inoue, et al.
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 2, pp. 121-128
Closed Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim, Tao Che, Ouliana Panova, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1574-1588.e19
Open Access | Times Cited: 373
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao, Jing Yu, Huan Wang, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 403-411
Closed Access | Times Cited: 211
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
A review: FDA-approved fluorine-containing small molecules from 2015 to 2022
Negar Sheikhi, Maryam Bahraminejad, Mina Saeedi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115758-115758
Closed Access | Times Cited: 42
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Étienne Billard, Alexandre Torbey, Antonio Inserra, et al.
Cellular Signalling (2025) Vol. 127, pp. 111588-111588
Closed Access | Times Cited: 3
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer Kricker, Clive P. Page, Fridrik Runar Gardarsson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1404-1433
Open Access | Times Cited: 58
“Selective” serotonin 5-HT2A receptor antagonists
Austen B. Casey, Meng Cui, Raymond G. Booth, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115028-115028
Open Access | Times Cited: 52
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 22
Flexible scaffold-based cheminformatics approach for polypharmacological drug design
Zhangcheng Chen, Jing Yu, Huan Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2194-2208.e22
Closed Access | Times Cited: 10
Molecular dynamics-based identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/GPR91
Aslihan Shenol, Michael Lückmann, Mette Trauelsen, et al.
Molecular Cell (2024) Vol. 84, Iss. 5, pp. 955-966.e4
Open Access | Times Cited: 8
A fiducial-assisted strategy compatible with resolving small MFS transporter structures in multiple conformations using cryo-EM
Pujun Xie, Yan Li, Gaëlle Lamon, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
Dohyun Im, Asuka Inoue, Takaaki Fujiwara, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs
Bryan L. Roth
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 7, pp. 535-544
Open Access | Times Cited: 60
Structure, dynamics and lipid interactions of serotonin receptors: excitements and challenges
Parijat Sarkar, Sukanya Mozumder, Aritra Bej, et al.
Biophysical Reviews (2020) Vol. 13, Iss. 1, pp. 101-122
Open Access | Times Cited: 55
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
Zhangcheng Chen, Luyu Fan, Huan Wang, et al.
Nature Neuroscience (2021) Vol. 25, Iss. 1, pp. 39-49
Closed Access | Times Cited: 47
Structural Insights Accelerate the Discovery of Opioid Alternatives
Tao Che, Bryan L. Roth
Annual Review of Biochemistry (2021) Vol. 90, Iss. 1, pp. 739-761
Open Access | Times Cited: 43
Molecular insights into psychedelic drug action
Samuel T. Slocum, Jeffrey F. DiBerto, Bryan L. Roth
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 24-38
Open Access | Times Cited: 42
Structural basis for recognition of antihistamine drug by human histamine receptor
Xueqian Peng, Linlin Yang, Zixuan Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits
Elk Kossatz, Rebeca Dı́ez-Alarcia, Supriya A. Gaitonde, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
Supriya A. Gaitonde, Charlotte Avet, Mario de la Fuente Revenga, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2753-2764
Open Access | Times Cited: 6
Structural insights into melatonin receptors
Benjamin Stauch, Linda C. Johansson, Vadim Cherezov
FEBS Journal (2019) Vol. 287, Iss. 8, pp. 1496-1510
Open Access | Times Cited: 49
The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone
Hidetsugu Asada, Asuka Inoue, Francois Marie Ngako Kadji, et al.
Structure (2019) Vol. 28, Iss. 4, pp. 418-425.e4
Open Access | Times Cited: 49
Update on GPCR-based targets for the development of novel antidepressants
Ioannis Mantas, Marcus Saarinen, Qing Xu, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 534-558
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top